Literature DB >> 26919315

Risk factors for baclofen pump infection in children: a multivariate analysis.

Heather S Spader1, Robert J Bollo1, Christian A Bowers1, Jay Riva-Cambrin1.   

Abstract

OBJECTIVE Intrathecal baclofen infusion systems to manage severe spasticity and dystonia are associated with higher infection rates in children than in adults. Factors unique to this population, such as poor nutrition and physical limitations for pump placement, have been hypothesized as the reasons for this disparity. The authors assessed potential risk factors for infection in a multivariate analysis. METHODS Patients who underwent implantation of a programmable pump and intrathecal catheter for baclofen infusion at a single center between January 1, 2000, and March 1, 2012, were identified in this retrospective cohort study. The primary end point was infection. Potential risk factors investigated included preoperative (i.e., demographics, body mass index [BMI], gastrostomy tube, tracheostomy, previous spinal fusion), intraoperative (i.e., surgeon, antibiotics, pump size, catheter location), and postoperative (i.e., wound dehiscence, CSF leak, and number of revisions) factors. Univariate analysis was performed, and a multivariate logistic regression model was created to identify independent risk factors for infection. RESULTS A total of 254 patients were evaluated. The overall infection rate was 9.8%. Univariate analysis identified young age, shorter height, lower weight, dehiscence, CSF leak, and number of revisions within 6 months of pump placement as significantly associated with infection. Multivariate analysis identified young age, dehiscence, and number of revisions as independent risk factors for infection. CONCLUSIONS Young age, wound dehiscence, and number of revisions were independent risk factors for infection in this pediatric cohort. A low BMI and the presence of either a gastrostomy or tracheostomy were not associated with infection and may not be contraindications for this procedure.

Entities:  

Keywords:  BMI = body mass index; ITB = intrathecal baclofen; PCH = Primary Children's Hospital; TBI = traumatic brain injury; VP = ventriculoperitoneal; baclofen pump; children; infection; spasticity

Mesh:

Substances:

Year:  2016        PMID: 26919315     DOI: 10.3171/2015.11.PEDS15421

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  3 in total

1.  Intrathecal baclofen therapy for treatment of spasticity in infants and small children under 6 years of age.

Authors:  Christian Hagemann; Ilka Schmitt; Grischa Lischetzki; Philip Kunkel
Journal:  Childs Nerv Syst       Date:  2019-08-09       Impact factor: 1.475

2.  Identification of complications in paediatric cerebral palsy treated with intrathecal baclofen pump: a descriptive analysis of 15 years at one institution.

Authors:  A Imerci; K J Rogers; C Pargas; J P Sees; F Miller
Journal:  J Child Orthop       Date:  2019-10-01       Impact factor: 1.548

3.  Cerebral Palsy Research Network Clinical Registry: Methodology and Baseline Report.

Authors:  Paul Gross; Mary Gannotti; Amy Bailes; Susan D Horn; Jacob Kean; Unni G Narayanan; Jerry Oakes; Garey Noritz
Journal:  Arch Rehabil Res Clin Transl       Date:  2020-04-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.